10th Oct 2022 12:00 pm |
RNS |
Director/PDMR Shareholding |
6th Oct 2022 5:30 pm |
RNS |
Block listing Interim Review |
3rd Oct 2022 5:00 pm |
RNS |
Issue of Equity and Total Voting Rights |
29th Sep 2022 9:00 am |
RNS |
Director/PDMR Shareholding |
14th Sep 2022 11:00 am |
RNS |
Director/PDMR Shareholding |
13th Sep 2022 5:00 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
13th Sep 2022 7:00 am |
RNS |
Interim results for the period ended 30 June 2022 |
12th Sep 2022 4:30 pm |
RNS |
Oxford Nanopore to present at upcoming conferences |
1st Sep 2022 6:30 pm |
RNS |
Issue of Equity and Total Voting Rights |
24th Aug 2022 7:00 am |
RNS |
Notice of Results |
11th Aug 2022 4:00 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
1st Aug 2022 5:30 pm |
RNS |
Issue of Equity and Total Voting Rights |
12th Jul 2022 5:00 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
11th Jul 2022 7:00 am |
RNS |
Sale and leaseback of headquarters building |
1st Jul 2022 5:16 pm |
RNS |
Issue of Equity and Total Voting Rights |
30th Jun 2022 7:15 am |
RNS |
Duncan Tatton-Brown appointed as Non-Exec Chair |
23rd Jun 2022 4:30 pm |
RNS |
Result of AGM |
13th Jun 2022 4:00 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
1st Jun 2022 4:00 pm |
RNS |
Issue of Equity and Total Voting Rights |
31st May 2022 6:30 pm |
RNS |
Director/PDMR Shareholding |
26th May 2022 7:00 am |
RNS |
ONT releases Remora:most comprehensive methylation |
20th May 2022 7:00 am |
RNS |
Oxford Nanopore announces tech updates |
19th May 2022 9:06 am |
RNS |
ONT opens user conference, rich science programme |
13th May 2022 7:00 am |
RNS |
ONT chosen for comprehensive human genome program |
11th May 2022 4:00 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
3rd May 2022 4:00 pm |
RNS |
Issue of Equity and Total Voting Rights |
12th Apr 2022 6:15 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
12th Apr 2022 1:01 pm |
RNS |
Director/PDMR Shareholding |
12th Apr 2022 1:01 pm |
RNS |
Director/PDMR Shareholding |
12th Apr 2022 1:00 pm |
RNS |
Director/PDMR Shareholding |
12th Apr 2022 7:00 am |
RNS |
Publication of Annual Report and Notice of AGM |
6th Apr 2022 1:00 pm |
RNS |
Block listing Interim Review |
5th Apr 2022 11:00 am |
RNS |
Director/PDMR Shareholding |
4th Apr 2022 2:00 pm |
RNS |
Genomics England expands Nanopore use in cancer |
1st Apr 2022 5:00 pm |
RNS |
Issue of Equity and Total Voting Rights |
1st Apr 2022 7:00 am |
RNS |
Agreement |
30th Mar 2022 2:00 pm |
RNS |
ONT shows new high-accuracy, high-output chemistry |
24th Mar 2022 7:00 am |
RNS |
Nanopore sequencing profiles TB: FIND evaluation |
23rd Mar 2022 2:02 pm |
RNS |
Oxford Nanopore releases Short Fragment Mode |
22nd Mar 2022 7:00 am |
RNS |
Preliminary Results and Guidance Update |